Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 ...

综上所述，对神经病理性疼痛的评估和管理需要一个综合的方法，包括全面的临床评估、症状分析和量表评估。随着研究的不断深入，我们相信将会有更多更精确的评估工具出现，帮助医生更好地了解和处理这一复杂的病症。

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

LONDON - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company with a market capitalization of $35.05 million ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

The following is a summary of “A Double-Blind Comparative Study of burstDR Versus Tonic Epidural Motor Cortex Stimulation for ...

The trigeminal nerve is a major nerve in the head that ... It relaxes the muscles to help ease the pain. The two drugs are sometimes used together. If medications aren’t enough to control ...

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...